EFGCP Steps Up Search for COO
Applications for the vacant Brussels-based post of chief operating officer at the European Forum for GCP (EFGCP) are due to close on Friday August 18. EFGCP says it has earmarked a proposed start date of September 18 for the successful candidate.
The role will involve the following responsibilities:
- ÂManagement of events, including conferences and workshops for between 40 and 150 participants and training courses.
- ÂFinding venues for events, negotiating contracts, handling logistics, managing speakers and delegates, and overseeing marketing and promotions.
- ÂProject management, including administrative and financial management of EFGCP participation in EU-funded projects and preparation of financial audits.
- ÂCoordination of internal meetings, managing the website and IT, public representation, office management, and accounting, VAT, and legal issues.
- ÂHuman resources (management of payroll and three-person staff).
According to the EFGCP, “The applicant should have strong self-motivation, interpersonal skills, be multi-tasks-oriented, possibly have experience in the healthcare sector and be able to work in a small team environment.”
It lists the job requirements as: experience in a coordination position and event organization; excellent written and oral communication skills in English (French is an asset); knowledge of financial management and bookkeeping and legal rules for associations based in Belgium; very well organized and caring for details; flexible, positive, and service-minded; excellent time management and respect of deadlines; and creative and resourceful problem-solving abilities.
Applications should include a CV in English and a one-page covering letter in English and be sent to jobs@efgcp.eu
Philip Ward is the European Editor for Applied Clinical Trials.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025